Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1

Background Myotonic dystrophy type 1 (DM1) is a neurologic disorder with known cardiac involvement, including left ventricular systolic dysfunction (LVSD), heart failure (HF), atrioventricular and intraventricular conduction system disease, and sudden death. We studied the prevalence of these condit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American heart journal 2010-12, Vol.160 (6), p.1137-1141.e1
Hauptverfasser: Bhakta, Deepak, MD, Groh, Miriam R., MS, Shen, Changyu, PhD, Pascuzzi, Robert M., MD, Groh, William J., MD, MPH
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1141.e1
container_issue 6
container_start_page 1137
container_title The American heart journal
container_volume 160
creator Bhakta, Deepak, MD
Groh, Miriam R., MS
Shen, Changyu, PhD
Pascuzzi, Robert M., MD
Groh, William J., MD, MPH
description Background Myotonic dystrophy type 1 (DM1) is a neurologic disorder with known cardiac involvement, including left ventricular systolic dysfunction (LVSD), heart failure (HF), atrioventricular and intraventricular conduction system disease, and sudden death. We studied the prevalence of these conditions and associated findings in a large population with DM1. Methods History, physical examination, genetic testing, and electrocardiography were performed on 406 patients with DM1, and cardiac imaging was performed on 180 (44.3%) of these patients. Results Left ventricular systolic dysfunction and clinical HF were found in 34 (18.9%) of 180 and in 23 (5.7%) of 406 of enrolled subjects, respectively, yielding an overall prevalence of LVSD/HF in 41 (10.1%) of 406. Increasing age, male sex, electrocardiographic conduction abnormalities, presence of atrial and ventricular arrhythmias, and implanted devices were all significantly associated with LVSD/HF, whereas cytosine-thiamine-guanine repeat length and neuromuscular severity score were not. The interval ≥240 milliseconds (relative risk 4.1, 95% CI 1.7-9.6, P = .001) and QRS duration ≥120 milliseconds (relative risk 4.2, 95% CI 2.0-8.5, P < .001) were significant predictors of LVSD/HF. The presence of LVSD/HF was also significantly associated with all-cause death (relative risk 3.9, 95% CI 2.3-6.4, P < .001) and cardiac death (relative risk 5.7, 95% CI 2.6-12.4, P < .001). Conclusions A significant prevalence of LVSD/HF exists in patients with DM1. The presence of LVSD/HF in DM1 is significantly associated with all-cause and cardiac death.
doi_str_mv 10.1016/j.ahj.2010.07.032
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_820957674</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002870310006794</els_id><sourcerecordid>820957674</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-b12e9940729b353d86d96067d74c67f7b61b7f51e8c02af77c2a63e2a70c82043</originalsourceid><addsrcrecordid>eNp9kl-L1TAQxYso7nX1A_giARGfep2kadIiLMjin4UFH9TnkKZTbmpuc03SlX57U3p1YR98ChN-Z5iZc4riJYU9BSrejXt9GPcMcg1yDxV7VOwotLIUkvPHxQ4AWNlIqC6KZzGOuRSsEU-LC0YpF0K0u2K5mUxAHbEnRx-SdjYt5LdNB-JwSOQOpxSsmZ0OJC4xeWcN6Zc4zJNJ1k9ETz05oA6JDNq6OSCx-bOfXYpbm-Pik582VQr-dFhIWk5I6PPiyaBdxBfn97L48enj9-sv5e3XzzfXH25Lw0Wdyo4ybFsOkrVdVVd9I_pWgJC95EbIQXaCdnKoKTYGmB6kNEyLCpmWYBoGvLos3m59T8H_mjEmdbTRoHN6Qj9HlaG2lvlimXz9gBz9HKY8nKI1cMEBGpopulEm-BgDDuoU7FGHRVFQqy1qVNkWtdqiQKpsS9a8OneeuyP2_xR_fcjAmzOgo9FuCHoyNt5zleR5yiZz7zcO88XuLAYVjcXJYG8DmqR6b_87xtUDtXE2e6PdT1ww3m-rIlOgvq35WeND1-TIlld_APNnv_E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504640081</pqid></control><display><type>article</type><title>Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Bhakta, Deepak, MD ; Groh, Miriam R., MS ; Shen, Changyu, PhD ; Pascuzzi, Robert M., MD ; Groh, William J., MD, MPH</creator><creatorcontrib>Bhakta, Deepak, MD ; Groh, Miriam R., MS ; Shen, Changyu, PhD ; Pascuzzi, Robert M., MD ; Groh, William J., MD, MPH</creatorcontrib><description>Background Myotonic dystrophy type 1 (DM1) is a neurologic disorder with known cardiac involvement, including left ventricular systolic dysfunction (LVSD), heart failure (HF), atrioventricular and intraventricular conduction system disease, and sudden death. We studied the prevalence of these conditions and associated findings in a large population with DM1. Methods History, physical examination, genetic testing, and electrocardiography were performed on 406 patients with DM1, and cardiac imaging was performed on 180 (44.3%) of these patients. Results Left ventricular systolic dysfunction and clinical HF were found in 34 (18.9%) of 180 and in 23 (5.7%) of 406 of enrolled subjects, respectively, yielding an overall prevalence of LVSD/HF in 41 (10.1%) of 406. Increasing age, male sex, electrocardiographic conduction abnormalities, presence of atrial and ventricular arrhythmias, and implanted devices were all significantly associated with LVSD/HF, whereas cytosine-thiamine-guanine repeat length and neuromuscular severity score were not. The interval ≥240 milliseconds (relative risk 4.1, 95% CI 1.7-9.6, P = .001) and QRS duration ≥120 milliseconds (relative risk 4.2, 95% CI 2.0-8.5, P &lt; .001) were significant predictors of LVSD/HF. The presence of LVSD/HF was also significantly associated with all-cause death (relative risk 3.9, 95% CI 2.3-6.4, P &lt; .001) and cardiac death (relative risk 5.7, 95% CI 2.6-12.4, P &lt; .001). Conclusions A significant prevalence of LVSD/HF exists in patients with DM1. The presence of LVSD/HF in DM1 is significantly associated with all-cause and cardiac death.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2010.07.032</identifier><identifier>PMID: 21146669</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Adult ; Biological and medical sciences ; Cardiac arrhythmia ; Cardiology. Vascular system ; Cardiovascular ; Disease Progression ; Diseases of striated muscles. Neuromuscular diseases ; Drug therapy ; Electrocardiography ; Female ; Follow-Up Studies ; Heart ; Heart attacks ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Heart Failure, Systolic - diagnosis ; Heart Failure, Systolic - etiology ; Heart Failure, Systolic - mortality ; Humans ; Kinases ; Male ; Medical sciences ; Muscular dystrophy ; Myotonic Dystrophy - complications ; Myotonic Dystrophy - mortality ; Neurology ; Prognosis ; Prospective Studies ; Risk Factors ; Severity of Illness Index ; Survival Rate - trends ; United States - epidemiology ; Ventricular Dysfunction, Left - diagnosis ; Ventricular Dysfunction, Left - etiology ; Ventricular Dysfunction, Left - mortality</subject><ispartof>The American heart journal, 2010-12, Vol.160 (6), p.1137-1141.e1</ispartof><rights>Mosby, Inc.</rights><rights>2010 Mosby, Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Mosby, Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Dec 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-b12e9940729b353d86d96067d74c67f7b61b7f51e8c02af77c2a63e2a70c82043</citedby><cites>FETCH-LOGICAL-c465t-b12e9940729b353d86d96067d74c67f7b61b7f51e8c02af77c2a63e2a70c82043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1504640081?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23740958$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21146669$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhakta, Deepak, MD</creatorcontrib><creatorcontrib>Groh, Miriam R., MS</creatorcontrib><creatorcontrib>Shen, Changyu, PhD</creatorcontrib><creatorcontrib>Pascuzzi, Robert M., MD</creatorcontrib><creatorcontrib>Groh, William J., MD, MPH</creatorcontrib><title>Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Background Myotonic dystrophy type 1 (DM1) is a neurologic disorder with known cardiac involvement, including left ventricular systolic dysfunction (LVSD), heart failure (HF), atrioventricular and intraventricular conduction system disease, and sudden death. We studied the prevalence of these conditions and associated findings in a large population with DM1. Methods History, physical examination, genetic testing, and electrocardiography were performed on 406 patients with DM1, and cardiac imaging was performed on 180 (44.3%) of these patients. Results Left ventricular systolic dysfunction and clinical HF were found in 34 (18.9%) of 180 and in 23 (5.7%) of 406 of enrolled subjects, respectively, yielding an overall prevalence of LVSD/HF in 41 (10.1%) of 406. Increasing age, male sex, electrocardiographic conduction abnormalities, presence of atrial and ventricular arrhythmias, and implanted devices were all significantly associated with LVSD/HF, whereas cytosine-thiamine-guanine repeat length and neuromuscular severity score were not. The interval ≥240 milliseconds (relative risk 4.1, 95% CI 1.7-9.6, P = .001) and QRS duration ≥120 milliseconds (relative risk 4.2, 95% CI 2.0-8.5, P &lt; .001) were significant predictors of LVSD/HF. The presence of LVSD/HF was also significantly associated with all-cause death (relative risk 3.9, 95% CI 2.3-6.4, P &lt; .001) and cardiac death (relative risk 5.7, 95% CI 2.6-12.4, P &lt; .001). Conclusions A significant prevalence of LVSD/HF exists in patients with DM1. The presence of LVSD/HF in DM1 is significantly associated with all-cause and cardiac death.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Disease Progression</subject><subject>Diseases of striated muscles. Neuromuscular diseases</subject><subject>Drug therapy</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Heart Failure, Systolic - diagnosis</subject><subject>Heart Failure, Systolic - etiology</subject><subject>Heart Failure, Systolic - mortality</subject><subject>Humans</subject><subject>Kinases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscular dystrophy</subject><subject>Myotonic Dystrophy - complications</subject><subject>Myotonic Dystrophy - mortality</subject><subject>Neurology</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Survival Rate - trends</subject><subject>United States - epidemiology</subject><subject>Ventricular Dysfunction, Left - diagnosis</subject><subject>Ventricular Dysfunction, Left - etiology</subject><subject>Ventricular Dysfunction, Left - mortality</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kl-L1TAQxYso7nX1A_giARGfep2kadIiLMjin4UFH9TnkKZTbmpuc03SlX57U3p1YR98ChN-Z5iZc4riJYU9BSrejXt9GPcMcg1yDxV7VOwotLIUkvPHxQ4AWNlIqC6KZzGOuRSsEU-LC0YpF0K0u2K5mUxAHbEnRx-SdjYt5LdNB-JwSOQOpxSsmZ0OJC4xeWcN6Zc4zJNJ1k9ETz05oA6JDNq6OSCx-bOfXYpbm-Pik582VQr-dFhIWk5I6PPiyaBdxBfn97L48enj9-sv5e3XzzfXH25Lw0Wdyo4ybFsOkrVdVVd9I_pWgJC95EbIQXaCdnKoKTYGmB6kNEyLCpmWYBoGvLos3m59T8H_mjEmdbTRoHN6Qj9HlaG2lvlimXz9gBz9HKY8nKI1cMEBGpopulEm-BgDDuoU7FGHRVFQqy1qVNkWtdqiQKpsS9a8OneeuyP2_xR_fcjAmzOgo9FuCHoyNt5zleR5yiZz7zcO88XuLAYVjcXJYG8DmqR6b_87xtUDtXE2e6PdT1ww3m-rIlOgvq35WeND1-TIlld_APNnv_E</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Bhakta, Deepak, MD</creator><creator>Groh, Miriam R., MS</creator><creator>Shen, Changyu, PhD</creator><creator>Pascuzzi, Robert M., MD</creator><creator>Groh, William J., MD, MPH</creator><general>Mosby, Inc</general><general>Mosby</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1</title><author>Bhakta, Deepak, MD ; Groh, Miriam R., MS ; Shen, Changyu, PhD ; Pascuzzi, Robert M., MD ; Groh, William J., MD, MPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-b12e9940729b353d86d96067d74c67f7b61b7f51e8c02af77c2a63e2a70c82043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Disease Progression</topic><topic>Diseases of striated muscles. Neuromuscular diseases</topic><topic>Drug therapy</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Heart Failure, Systolic - diagnosis</topic><topic>Heart Failure, Systolic - etiology</topic><topic>Heart Failure, Systolic - mortality</topic><topic>Humans</topic><topic>Kinases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscular dystrophy</topic><topic>Myotonic Dystrophy - complications</topic><topic>Myotonic Dystrophy - mortality</topic><topic>Neurology</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Survival Rate - trends</topic><topic>United States - epidemiology</topic><topic>Ventricular Dysfunction, Left - diagnosis</topic><topic>Ventricular Dysfunction, Left - etiology</topic><topic>Ventricular Dysfunction, Left - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhakta, Deepak, MD</creatorcontrib><creatorcontrib>Groh, Miriam R., MS</creatorcontrib><creatorcontrib>Shen, Changyu, PhD</creatorcontrib><creatorcontrib>Pascuzzi, Robert M., MD</creatorcontrib><creatorcontrib>Groh, William J., MD, MPH</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhakta, Deepak, MD</au><au>Groh, Miriam R., MS</au><au>Shen, Changyu, PhD</au><au>Pascuzzi, Robert M., MD</au><au>Groh, William J., MD, MPH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>160</volume><issue>6</issue><spage>1137</spage><epage>1141.e1</epage><pages>1137-1141.e1</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><abstract>Background Myotonic dystrophy type 1 (DM1) is a neurologic disorder with known cardiac involvement, including left ventricular systolic dysfunction (LVSD), heart failure (HF), atrioventricular and intraventricular conduction system disease, and sudden death. We studied the prevalence of these conditions and associated findings in a large population with DM1. Methods History, physical examination, genetic testing, and electrocardiography were performed on 406 patients with DM1, and cardiac imaging was performed on 180 (44.3%) of these patients. Results Left ventricular systolic dysfunction and clinical HF were found in 34 (18.9%) of 180 and in 23 (5.7%) of 406 of enrolled subjects, respectively, yielding an overall prevalence of LVSD/HF in 41 (10.1%) of 406. Increasing age, male sex, electrocardiographic conduction abnormalities, presence of atrial and ventricular arrhythmias, and implanted devices were all significantly associated with LVSD/HF, whereas cytosine-thiamine-guanine repeat length and neuromuscular severity score were not. The interval ≥240 milliseconds (relative risk 4.1, 95% CI 1.7-9.6, P = .001) and QRS duration ≥120 milliseconds (relative risk 4.2, 95% CI 2.0-8.5, P &lt; .001) were significant predictors of LVSD/HF. The presence of LVSD/HF was also significantly associated with all-cause death (relative risk 3.9, 95% CI 2.3-6.4, P &lt; .001) and cardiac death (relative risk 5.7, 95% CI 2.6-12.4, P &lt; .001). Conclusions A significant prevalence of LVSD/HF exists in patients with DM1. The presence of LVSD/HF in DM1 is significantly associated with all-cause and cardiac death.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>21146669</pmid><doi>10.1016/j.ahj.2010.07.032</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-8703
ispartof The American heart journal, 2010-12, Vol.160 (6), p.1137-1141.e1
issn 0002-8703
1097-6744
language eng
recordid cdi_proquest_miscellaneous_820957674
source MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland
subjects Adult
Biological and medical sciences
Cardiac arrhythmia
Cardiology. Vascular system
Cardiovascular
Disease Progression
Diseases of striated muscles. Neuromuscular diseases
Drug therapy
Electrocardiography
Female
Follow-Up Studies
Heart
Heart attacks
Heart failure, cardiogenic pulmonary edema, cardiac enlargement
Heart Failure, Systolic - diagnosis
Heart Failure, Systolic - etiology
Heart Failure, Systolic - mortality
Humans
Kinases
Male
Medical sciences
Muscular dystrophy
Myotonic Dystrophy - complications
Myotonic Dystrophy - mortality
Neurology
Prognosis
Prospective Studies
Risk Factors
Severity of Illness Index
Survival Rate - trends
United States - epidemiology
Ventricular Dysfunction, Left - diagnosis
Ventricular Dysfunction, Left - etiology
Ventricular Dysfunction, Left - mortality
title Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T17%3A54%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20mortality%20with%20left%20ventricular%20systolic%20dysfunction%20and%20heart%20failure%20in%20adults%20with%20myotonic%20dystrophy%20type%201&rft.jtitle=The%20American%20heart%20journal&rft.au=Bhakta,%20Deepak,%20MD&rft.date=2010-12-01&rft.volume=160&rft.issue=6&rft.spage=1137&rft.epage=1141.e1&rft.pages=1137-1141.e1&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/j.ahj.2010.07.032&rft_dat=%3Cproquest_cross%3E820957674%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504640081&rft_id=info:pmid/21146669&rft_els_id=1_s2_0_S0002870310006794&rfr_iscdi=true